Pfizer Inc. (SNSE:PFE)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CLP 135.80 trillion. The enterprise value is 179.64 trillion.

Market Cap	135.80T
Enterprise Value	179.64T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.32%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.40 and the forward PE ratio is 8.63.

PE Ratio	14.40
Forward PE	8.63
PS Ratio	2.25
PB Ratio	1.52
P/TBV Ratio	n/a
P/FCF Ratio	13.64
P/OCF Ratio	10.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.55, with an EV/FCF ratio of 18.04.

EV / Earnings	19.04
EV / Sales	3.08
EV / EBITDA	7.55
EV / EBIT	10.89
EV / FCF	18.04

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	743.89M
Profits Per Employee	116.46M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-657.39B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.76% in the last 52 weeks. The beta is 0.71, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-6.76%
50-Day Moving Average	26.06
200-Day Moving Average	26.06
Relative Strength Index (RSI)	0.00
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.94

Income Statement

In the last 12 months, Pfizer had revenue of CLP 60.25 trillion and earned 9.43 trillion in profits. Earnings per share was 1,656.68.

Revenue	60.25T
Gross Profit	45.08T
Operating Income	17.06T
Pretax Income	8.78T
Net Income	9.43T
EBITDA	23.47T
EBIT	17.06T
Earnings Per Share (EPS)	1,656.68

Balance Sheet

The company has 14.38 trillion in cash and 59.44 trillion in debt, giving a net cash position of -45,059.83 billion.

Cash & Cash Equivalents	14.38T
Total Debt	59.44T
Net Cash	-45,059.83B
Net Cash Per Share	n/a
Equity (Book Value)	89.34T
Book Value Per Share	15,663.23
Working Capital	9.91T

Cash Flow

In the last 12 months, operating cash flow was 12.55 trillion and capital expenditures -2,592.15 billion, giving a free cash flow of 9.96 trillion.

Operating Cash Flow	12.55T
Capital Expenditures	-2,592.15B
Free Cash Flow	9.96T
FCF Per Share	n/a

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 1,640.06, which amounts to a dividend yield of 6,293.40%.

Dividend Per Share	1,640.06
Dividend Yield	6,293.40%
Dividend Growth (YoY)	3.91%
Years of Dividend Growth	1
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	6,293.21%
Earnings Yield	6.95%
FCF Yield	7.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7